Brief: Y-Mabs Therapeutics Inc Reports Quarterly Earnings Per Share Of $0.03
30/03/2023 21:20
March 30 (Reuters) - Y-mAbs Therapeutics Inc YMAB.O :
* Y-MABS REPORTS FOURTH QUARTER AND FULL-YEAR 2022 FINANCIAL
RESULTS AND RECENT CORPORATE DEVELOPMENTS
* Y-MABS THERAPEUTICS INC - MANAGEMENT REITERATES 2023
FINANCIAL
GUIDANCE
* Y-MABS THERAPEUTICS INC - QTRLY EARNINGS PER SHARE $0.03
Source text for Eikon: ID:nGNXbV1NQ8
Further company coverage: YMAB.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Y-mAbs Therapeutics
See all newsY-mAbs Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Y-mAbs Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Y-mAbs Therapeutics' Q2 revenue falls 14%
Brief: Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics
Y-mAbs Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary